Table of Contents
Chapter 1. Global Renal Anemia Market Executive Summary
1.1. Global Renal Anemia Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Anemia Type
1.3.2. By Treatment Type
1.3.3. By Disease Severity
1.3.4. By End-User
1.3.5. By Route of Administration
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Renal Anemia Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Renal Anemia Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Chronic Kidney Disease (CKD)
3.1.2. Growing Adoption of Erythropoiesis-Stimulating Agents (ESAs)
3.1.3. Rising Demand for Non-Invasive Treatment Options
3.2. Market Challenges
3.2.1. High Cost of Treatment
3.2.2. Side Effects Associated with ESAs
3.3. Market Opportunities
3.3.1. Development of Non-ESA-Based Therapies
3.3.2. Targeted Drug Delivery Systems
3.3.3. Personalized Treatment Regimens
Chapter 4. Global Renal Anemia Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Renal Anemia Market Size & Forecasts by Anemia Type 2022-2032
5.1. Segment Dashboard
5.2. Global Renal Anemia Market: Anemia Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Iron Deficiency Anemia
5.2.2. Vitamin B12 Deficiency Anemia
5.2.3. Folate Deficiency Anemia
5.2.4. Aplastic Anemia
5.2.5. Hemolytic Anemia
5.2.6. Sickle Cell Anemia
Chapter 6. Global Renal Anemia Market Size & Forecasts by Treatment Type 2022-2032
6.1. Segment Dashboard
6.2. Global Renal Anemia Market: Treatment Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Erythropoiesis-Stimulating Agents (ESAs)
6.2.2. Iron Supplementation
6.2.3. Vitamin B12 Supplementation
6.2.4. Folate Supplementation
6.2.5. Transfusion Therapy
6.2.6. Bone Marrow Transplant
Chapter 7. Global Renal Anemia Market Size & Forecasts by Disease Severity 2022-2032
7.1. Segment Dashboard
7.2. Global Renal Anemia Market: Disease Severity Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Mild
7.2.2. Moderate
7.2.3. Severe
Chapter 8. Global Renal Anemia Market Size & Forecasts by End-User 2022-2032
8.1. Segment Dashboard
8.2. Global Renal Anemia Market: End-User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospitals
8.2.2. Dialysis Centers
8.2.3. Clinics
8.2.4. Home Healthcare
Chapter 9. Global Renal Anemia Market Size & Forecasts by Route of Administration 2022-2032
9.1. Segment Dashboard
9.2. Global Renal Anemia Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
9.2.1. Intravenous
9.2.2. Subcutaneous
9.2.3. Oral
Chapter 10. Global Renal Anemia Market Size & Forecasts by Region 2022-2032
10.1. North America Renal Anemia Market
10.1.1. U.S. Renal Anemia Market
10.1.1.1. Anemia Type breakdown size & forecasts, 2022-2032
10.1.1.2. Treatment Type breakdown size & forecasts, 2022-2032
10.1.1.3. Disease Severity breakdown size & forecasts, 2022-2032
10.1.1.4. End-User breakdown size & forecasts, 2022-2032
10.1.1.5. Route of Administration breakdown size & forecasts, 2022-2032
10.1.2. Canada Renal Anemia Market
10.2. Europe Renal Anemia Market
10.2.1. U.K. Renal Anemia Market
10.2.2. Germany Renal Anemia Market
10.2.3. France Renal Anemia Market
10.2.4. Spain Renal Anemia Market
10.2.5. Italy Renal Anemia Market
10.2.6. Rest of Europe Renal Anemia Market
10.3. Asia-Pacific Renal Anemia Market
10.3.1. China Renal Anemia Market
10.3.2. India Renal Anemia Market
10.3.3. Japan Renal Anemia Market
10.3.4. Australia Renal Anemia Market
10.3.5. South Korea Renal Anemia Market
10.3.6. Rest of Asia Pacific Renal Anemia Market
10.4. Latin America Renal Anemia Market
10.4.1. Brazil Renal Anemia Market
10.4.2. Mexico Renal Anemia Market
10.4.3. Rest of Latin America Renal Anemia Market
10.5. Middle East & Africa Renal Anemia Market
10.5.1. Saudi Arabia Renal Anemia Market
10.5.2. South Africa Renal Anemia Market
10.5.3. Rest of Middle East & Africa Renal Anemia Market
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Roche
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. AstraZeneca PLC
11.3.3. Fresenius Medical Care AG & Co. KGAA
11.3.4. Johnson & Johnson
11.3.5. Astellas Pharma Inc.
11.3.6. Amgen Inc.
11.3.7. Otsuka Pharmaceutical Co., Ltd.
11.3.8. Merck & Co., Inc.
11.3.9. Teva Pharmaceutical Industries Ltd.
11.3.10. Novartis AG
11.3.11. AbbVie Inc.
11.3.12. Sanofi
11.3.13. Pfizer Inc.
11.3.14. Baxter International Inc.
11.3.15. DaVita Inc.
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes